日本語 >>
TOP page
Journal Articles
（Last updated : 2026-09-01 09:36:04）
Eriko Kajimoto
Department
Kawasaki Medical School Kawasaki Medical School, Department of Nephrology and Hypertension,
Position
Instructor
■
Journal Articles
1.
2026/04
Finerenone Improves Albuminuria via MR-TRPC Signaling in Diabetic Kidney Disease
2.
2026/01/01
Endothelial dysfunction accelerates AKI to CKD transition by promoting β-catenin activation in macrophages
3.
2025/11/06
The Nonsteroidal Mineralocorticoid Receptor Blocker Esaxerenone reduces glomerular hyperfiltration and albuminuria
4.
2025/11
The Nonsteroidal Mineralocorticoid Receptor Blocker Esaxerenone reduces glomerular hyperfiltration and albuminuria.
5.
2024/11/02
ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice
6.
2023/09
Activation of the inflammasome drives peritoneal deterioration in a mouse model of peritoneal fibrosis.
7.
2023
The deficient of eNOS-NO pathway exacerbates kidney dysfunction
via inflammasome activation in diabetic kidney disease
8.
2021/08
A rare case of amyloid light-chain amyloidosis with bilateral perirenal hematoma shortly after initiation of peritoneal dialysis.
Display 5 items
Display all(8)
■
Presentations
1.
2024/09/15
Elucidation of the Molecular Mechanism of Albuminuria Improvement by Non-Steroidal Mineralocorticoid Receptor (MR) Antagonists Finerenone. （Poster notice，General）
2.
2024/09/15
Endothelial Dysfunction Fuels Progression from Acute to Chronic Kidney Disease through Macrophage-Mediated β-Catenin Activation （Poster notice，General）
3.
2024/09/15
Impaired Glomerular Epithelial Cell sGC Activation Promotes Glomer- Significance of Glomerular Epithelial Cell sGC Activation via eNOS-NO Pathway in Diabetic Kidney Disease （Poster notice，General）
4.
2024/09/15
SGLT2 Inhibition suppresses residual nephron glomerular hyperfiltration in Non-Diabetic Chronic Kidney Disease （Poster notice，General）
